MRS2500 tetraammonium is a potent, selective and stable antagonist of the P2Y1 receptor ( K i =0.78 nM for recombinant human P2Y1 receptor ). MRS2500 tetraammonium inhibits the ADP-induced aggregation of human platelets with an IC 50 value of 0.95 nM. Antithrombotic activity.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > P2Y Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.